Opportunity for potential vaccine entrants in India shrinking: Analysts

The government has recently set the maximum price that private hospitals can charge for the three Covid-19 vaccines currently available in India

The opportunity for potential vaccine entrants in India continues to shrink with potential entrants likely to remain limited in volume with private market players, says the latest note by Jefferies.
 
"Four - six Covid vaccines including Sputnik-V, which are due to start supplying in the next few months have a shrinking opportunity size with the government's aggressive pre-purchases. These vaccines include Sputnik-V (Dr. Reddy's), Zycov-D (Cadila Healthcare), Covovax (Novavax / Serum Institute), Johnson & Johnson (J&J) Vaccine (J&J/Biological E) and Moderna+Pfizer vaccines if at all,” wrote Abhishek Sharma, an analyst at Jefferies in a recent note.
 
The research